Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott Omacor Triglyceride Therapy Clears FDA; Reliant Is Likely Marketer

Executive Summary

Reliant appears ready to expand its cholesterol therapy franchise with Omacor

You may also be interested in...



Reliant Omacor Launch Funded Through IPO; Launch Set For Late 2005

Reliant Pharmaceuticals will raise cash through an initial public offering to pay for a sales force expansion for the launch of the triglyercide therapy Omacor

Reliant Omacor Launch Funded Through IPO; Launch Set For Late 2005

Reliant Pharmaceuticals will raise cash through an initial public offering to pay for a sales force expansion for the launch of the triglyercide therapy Omacor

Reliant Will Add Antara, Omacor To Cardiovascular Product Line In 2005

Reliant will launch two recently-approved cardiovascular products, Antara and Omacor, in 2005

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045018

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel